137 related articles for article (PubMed ID: 17067639)
1. Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors.
Ryman-Rasmussen JP; Griffith A; Oloff S; Vaidehi N; Brown JT; Goddard WA; Mailman RB
Neuropharmacology; 2007 Feb; 52(2):562-75. PubMed ID: 17067639
[TBL] [Abstract][Full Text] [Related]
2. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
[TBL] [Abstract][Full Text] [Related]
4. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR
J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
6. Effects of YM 435 and A 77636 on dopamine D-1 receptors in bovine retina in vitro.
Ofori S; De Raad S; Bugnon O; Schorderet M
Gen Pharmacol; 1995 Jan; 26(1):51-7. PubMed ID: 7713366
[TBL] [Abstract][Full Text] [Related]
7. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
8. (+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist.
Sit SY; Xie K; Jacutin-Porte S; Taber MT; Gulwadi AG; Korpinen CD; Burris KD; Molski TF; Ryan E; Xu C; Wong H; Zhu J; Krishnananthan S; Gao Q; Verdoorn T; Johnson G
J Med Chem; 2002 Aug; 45(17):3660-8. PubMed ID: 12166939
[TBL] [Abstract][Full Text] [Related]
9. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer.
Kong MM; Fan T; Varghese G; O'dowd BF; George SR
Mol Pharmacol; 2006 Jul; 70(1):78-89. PubMed ID: 16597839
[TBL] [Abstract][Full Text] [Related]
11. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
Saklayen SS; Mabrouk OS; Pehek EA
J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
[TBL] [Abstract][Full Text] [Related]
12. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
[TBL] [Abstract][Full Text] [Related]
13. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
Daly SA; Waddington JL
Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.
Mannoury la Cour C; Vidal S; Pasteau V; Cussac D; Millan MJ
Neuropharmacology; 2007 Mar; 52(3):1003-14. PubMed ID: 17178132
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
[TBL] [Abstract][Full Text] [Related]
16. The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats.
Bubenikova-Valesova V; Svoboda J; Horacek J; Vales K
Int J Neuropsychopharmacol; 2009 Aug; 12(7):873-83. PubMed ID: 19154630
[TBL] [Abstract][Full Text] [Related]
17. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
18. An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.
Svensson KA; Heinz BA; Schaus JM; Beck JP; Hao J; Krushinski JH; Reinhard MR; Cohen MP; Hellman SL; Getman BG; Wang X; Menezes MM; Maren DL; Falcone JF; Anderson WH; Wright RA; Morin SM; Knopp KL; Adams BL; Rogovoy B; Okun I; Suter TM; Statnick MA; Gehlert DR; Nelson DL; Lucaites VL; Emkey R; DeLapp NW; Wiernicki TR; Cramer JW; Yang CR; Bruns RF
J Pharmacol Exp Ther; 2017 Jan; 360(1):117-128. PubMed ID: 27811173
[TBL] [Abstract][Full Text] [Related]
19. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
Gulwadi AG; Korpinen CD; Mailman RB; Nichols DE; Sit SY; Taber MT
J Pharmacol Exp Ther; 2001 Feb; 296(2):338-44. PubMed ID: 11160615
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys.
Cai JX; Arnsten AF
J Pharmacol Exp Ther; 1997 Oct; 283(1):183-9. PubMed ID: 9336323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
